ReviewFrontiers in molecular biosciences2021

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: "The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis".

Miguel Sampayo-Cordero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.